Open-label Safety and Efficacy of Sodium Zirconium Cyclosilicate for up to 12 Months
NCT02163499
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
751
Enrollment
INDUSTRY
Sponsor class
Conditions
Hyperkalemia
Interventions
DRUG:
Sodium Zirconium Cyclosilicate
Sponsor
ZS Pharma, Inc.